Clinical Trials in Los Angeles

Showing 2301-2320 of 14,465 trials

A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors

NCT06730750

This is a study of BMS-986490 as a monotherapy and in combination with bevacizumab in participants with select advanced solid tumors known to express CEACAM5.

Advanced Solid Tumors

Bristol-Myers Squibb360 participantsStarted Feb 2025

Los Angeles, California, United States • Grand Rapids, Michigan, United States • Hackensack, New Jersey, United States +3 more locations

Active Not RecruitingPhase 2< 1 mile

A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC

NCT05611671

This is a Phase 2b randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of three active dose regimens of MORF-057 in adult patients with moderately to severely active Ulcerative Colitis (UC).

Inflammatory Bowel DiseasesColitis, Ulcerative

Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)280 participantsStarted Nov 2022

Sun City, Arizona, United States • Lancaster, California, United States • Los Angeles, California, United States +99 more locations

A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors

A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC

Find Trials by Condition in Los Angeles

A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis

Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant

Laryngeal and Vocal Tract Strategies to Reduce Vocal Fold Contact Pressure

A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis

A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)

Open Label, Dose-finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Participants With Suspected or Confirmed Bacterial Infections

Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's Transformation

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014)

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.

ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients

Study of Oral Food Challenge Biomarkers (SAFER)

An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)

An Interventional Study of Infigratinib in Children With Hypochondroplasia

COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"